[1]
|
中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版) [J]. 中华神经科杂志, 2022, 55(9): 931-949.
|
[2]
|
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M.B., Grisold, W., Kimura, A., Ohta, K., Iizuka, T., Guzman, M., Graus, F., Moss, S.J., Balice-Gordon, R. and Dalmau, J. (2010) Antibodies to the GABA(B) Receptor in Limbic Encephalitis with Seizures: Case Series and Characterisation of the Antigen. The Lancet. Neurology, 9, 67-76. https://doi.org/10.1016/S1474-4422(09)70324-2
|
[3]
|
Höftberger, R., Titulaer, M.J., Sabater, L., Dome, B., Rózsás, A., Hegedus, B., Hoda, M.A., Laszlo, V., Ankersmit, H.J., Harms, L., Boyero, S., de Felipe, A., Saiz, A., Dalmau, J. and Graus, F. (2013) Encephalitis and GABAB Receptor Antibodies: Novel Findings in a New Case Series of 20 Pa-tients. Neurology, 81, 1500-1506.
https://doi.org/10.1212/WNL.0b013e3182a9585f
|
[4]
|
Wen, X., Wang, B., Wang, C., Han, C. and Guo, S. (2021) A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors. Neu-ropsychiatric Disease and Treatment, 17, 99-110.
https://doi.org/10.2147/NDT.S289942
|
[5]
|
Vogrig, A., Pegat, A., Villagrán-García, M., Wucher, V., Attignon, V., Sohier, E., Brevet, M., Rogemond, V., Pinto, A.L., Muñiz-Castrillo, S., Peter, E., Robert, M., Picard, G., Hopes, L., Psimaras, D., Terra, A., Perrin, C., Cogne, D., Tabone-Eglinger, S., Martinez, S., et al. (2023) Different Genetic Signa-tures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes. An-nals of Neurology, 94, 1102-1115.
https://doi.org/10.1002/ana.26784
|
[6]
|
Seery, N., Butzkueven, H., O’Brien, T.J. and Monif, M. (2022) Rare Anti-body-Mediated and Seronegative Autoimmune Encephalitis: An Update. Autoimmunity Reviews, 21, 103118. https://doi.org/10.1016/j.autrev.2022.103118
|
[7]
|
Kass, I., Hoke, D.E., Costa, M.G., Reboul, C.F., Porebski, B.T., Cowieson, N.P., Leh, H., Pennacchietti, E., McCoey, J., Kleifeld, O., Borri Voltattorni, C., Langley, D., Roome, B., Mackay, I.R., Christ, D., Perahia, D., Buckle, M., Paiardini, A., De Biase, D. and Buckle, A.M. (2014) Cofac-tor-Dependent Conformational Heterogeneity of GAD65 and Its Role in Autoimmunity and Neurotransmitter Homeosta-sis. Proceedings of the National Academy of Sciences of the United States of America, 111, E2524-E2529. https://doi.org/10.1073/pnas.1403182111
|
[8]
|
Budhram, A., Sechi, E., Flanagan, E.P., Dubey, D., Zekeridou, A., Shah, S.S., Gadoth, A., Naddaf, E., McKeon, A., Pittock, S.J. and Zalewski, N.L. (2021) Clinical Spectrum of High-Titre GAD65 Antibodies. Journal of Neurology, Neurosurgery, and Psychiatry, 92, 645-654. https://doi.org/10.1136/jnnp-2020-325275
|
[9]
|
Alferes, A.R., Carvalho, I., Jorge, A., Lemos, J.M. and Batista, S. (2024) Recurrent Rhombencephalitis Associated with Anti-GAD65 Antibody. Neurology, 102, e208040. https://doi.org/10.1212/WNL.0000000000208040
|
[10]
|
McKeon, A. and Tracy, J.A. (2017) GAD65 Neurological Autoimmunity. Muscle & Nerve, 56, 15-27.
https://doi.org/10.1002/mus.25565
|
[11]
|
Wang, S., Hou, H., Tang, Y., Zhang, S., Wang, G., Guo, Z., Zhu, L. and Wu, J. (2023) An Overview on CV2/CRMP5 Antibody-Associated Paraneoplastic Neurological Syndromes. Neural Regeneration Research, 18, 2357-2364.
https://doi.org/10.4103/1673-5374.371400
|
[12]
|
Graus, F. and Dalmau, J. (2012) Paraneoplastic Neurological Syn-dromes. Current Opinion in Neurology, 25, 795-801.
https://doi.org/10.1097/WCO.0b013e328359da15
|
[13]
|
Ding, J., Xu, D., Lv, J., Wu, T., Li, J., Tian, M. and Lian, Y. (2022) Pulmonary Infection and Baseline mRS Scores Predict Poor Prognosis in Anti-GABABR Encephalitis. Frontiers in Immunology, 13, 918064.
https://doi.org/10.3389/fimmu.2022.918064
|
[14]
|
Huang, T., Liu, F., Wang, B., Wang, C., Hao, M. and Guo, S. (2023) Clinical Characteristics and Prognosis in Patients with Neuronal Surface Antibody-Mediated Autoimmune En-cephalitis: A Single-Center Cohort Study in China. Frontiers in Immunology, 14, 1213532. https://doi.org/10.3389/fimmu.2023.1213532
|
[15]
|
Bettler, B., Kaupmann, K., Mosbacher, J. and Gassmann, M. (2004) Molecular Structure and Physiological Functions of GABA(B) Receptors. Physiological Reviews, 84, 835-867. https://doi.org/10.1152/physrev.00036.2003
|
[16]
|
王宇新, 高培毅. 抗γ-氨基丁酸B型受体脑炎的磁共振成像特征分析[J]. 中华医学杂志, 2020, 100(29): 2309-2312.
|
[17]
|
Liu, X., Yu, T., Zhao, X., Li, G., Lv, R., Ai, L. and Wang, Q. (2022) 18 F-Fluorodeoxy-Glucose Positron Emission Tomography Pattern and Prognostic Predictors in Pa-tients with Anti-GABAB Receptor Encephalitis. CNS Neuroscience & Therapeutics, 28, 269-278. https://doi.org/10.1111/cns.13767
|
[18]
|
Lin, J., Li, C., Li, A., Liu, X., Chen, C., Gong, X., Zhou, D. and Hong, Z. (2021) Long-Term Cognitive and Neuropsychiatric Outcomes of Anti-GABABR Encephalitis Patients: A Prospective Study. Journal of Neuroimmunology, 351, 577471. https://doi.org/10.1016/j.jneuroim.2020.577471
|
[19]
|
Sun, T., Zhao, D., Zhang, G., Huang, Y., Guo, J., Jiang, W., Jia, R., Maimaiti, M., Liu, J., Bu, N., Li, Z., Yan, Y., Zhang, X., Sun, C., Zhao, C., Jia, X., Mao, B., Tian, H., Liu, Y., Chen, Z., et al. (2023) Late-Onset Anti-GABAB Receptor En-cephalitis: Clinical Characteristics and Outcomes Differing from Early-Onset Patients. Neurology(R) Neuroimmunology & Neuroinflammation, 10, e200131. https://doi.org/10.1212/NXI.0000000000200131
|